0.47 Neurocrine Biosciences (NASDAQ:NBIX) shareholders have endured a 28% loss from investing in the stock three years ago

News


<< back

Neurocrine Biosciences (NASDAQ:NBIX) shareholders have endured a 28% loss from investing in the stock three years ago
Date: 2023-07-18 [news.yahoo.com]

READ THE FULL NEWS >>
×